By creator to www.docwirenews.com
This text was initially revealed here
Transplant Proc. 2021 Jul 29:S0041-1345(21)00526-1. doi: 10.1016/j.transproceed.2021.07.045. On-line forward of print.
ABSTRACT
The extreme acute respiratory syndrome coronavirus 2 coronavirus illness 2019 (COVID-19) international pandemic has ushered in an period of hesitation in performing transplants in affected sufferers. This stems from the paucity of knowledge concerning the testing modalities, long-term implications, and unsure prognosis on this group of sufferers. Present steerage from the Facilities for Illness Management recommends assessing signs moderately than polymerase chain response (PCR) positivity. In mild of those suggestions, we describe a case of an orthotopic liver transplant in a affected person contaminated with COVID-19 with persistent PCR positivity for 40 days earlier than retransplant. The affected person’s perioperative and postoperative course was uncomplicated. Our expertise leads us to advocate for liver transplants in sufferers who’re PCR optimistic for COVID-19 after cautious individualized and multidisciplinary analysis concerning their liver illness and COVID-19 symptomatology.
PMID:34446305 | DOI:10.1016/j.transproceed.2021.07.045
— to www.docwirenews.com
